GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnsilica Regulatory News (ENSI)

Share Price Information for Ensilica (ENSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.50
Bid: 49.00
Ask: 50.00
Change: 4.00 (8.51%)
Spread: 1.00 (2.041%)
Open: 47.00
High: 51.00
Low: 47.00
Prev. Close: 47.00
ENSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to AIM and First Day of Dealings

24 May 2022 07:00

RNS Number : 5204M
EnSilica PLC
24 May 2022
 

24 May 2022

EnSilica plc

("EnSilica," the "Company" or the "Group")

 

Admission to trading on AIM and First Day of Dealings

 

EnSilica, a leading designer and supplier of mixed signal ASICs (Application Specific Integrated Circuits), is pleased to announce the admission of its Ordinary Shares to trading on the AIM market of the London Stock Exchange. Dealings commenced at 8.00am today, Tuesday 24 May 2022, under the ticker "ENSI".

 

EnSilica provides an end-to-end service for the design and supply of mixed signal ASICs, outsourcing certain elements such as the wafer fabrication of the manufacturing and packaging to third parties - otherwise known as a Fabless Semiconductor Model.

 

EnSilica has raised £6 million through a placing and subscription of 12,000,000 Ordinary Shares at a price of 50p per share (the "Placing Price") and has a market capitalisation of approximately £37.6 million at the Placing Price.

 

The Directors believe that the Group has reached a stage in its development where it will benefit from a quotation on AIM and that, as well as providing the Company with the net proceeds of the Fundraising, this will:

· enhance both transparency and international profile of EnSilica with existing and potential customers;

· allow the Company to access equity capital creating flexibility to fund growth and support potential M&A opportunities;

· enable EnSilica to attract, recruit and retain key employees who may be further incentivised through share option schemes; and

· create a platform for existing shareholders to participate in the future growth of the Company.

 

Allenby Capital is acting as Nominated Adviser and Sole Broker to the Company and the placing.

 

Ian Lankshear, Chief Executive Officer of EnSilica commented:

 

"Our admission to AIM represents a significant endorsement of our business which I believe creates an ideal platform from which to accelerate our growth ambitions.

 

"We have an outstanding team who have all helped established our market leading reputation and we are truly excited by the many opportunities our quoted status will bring."

 

For further information please visit www.ensilica.com or contact:

EnSilica plc

Ian Lankshear, Chief Executive Officer

Matthew Wethey, Chief Financial Officer

 

Via Vigo Consulting

+44 (0)20 7390 0233

Allenby Capital Limited, Nominated Adviser & Broker

Jeremy Porter / Vivek Bhardwaj (Corporate Finance)

Joscelin Pinnington/Tony Quirke (Sales & Corporate Broking)

 

Tel: +44 (0)20 3328 5656

info@allenbycapital.com

 

Vigo Consulting (Investor & Financial Public Relations)

Jeremy Garcia / Tara Benniman

ensilica@vigoconsulting.com

+44 (0)20 7390 0233

 

Confirmation regarding share options over existing ordinary shares

 

As set out in the Company's Admission Document, the following significant shareholders (as defined in the AIM Rules for Companies) have agreed to provide the number of shares specified below to benefit employees of the Company through the grant of options at the Placing Price of 50p per share.

 

Name

Total no. of ordinary shares held

Total no. of ordinary shares held (%)

No. of ordinary shares provided for employee share options

Ian William Ernest Lankshear

16,040,358

21.32%

1,592,239

Richard Ashley Hamer*

7,144,990

9.50%

724,499

Marc Castells*

5,786,554

7.69%

588,655

Richard Neil Marley*

5,786,554

7.69%

588,655

Nicholas Henry Weiner

3,457,737

4.60%

345,774

Philip Andrew Faulkner

3,457,737

4.60%

345,774

David Andrew Wheeler

3,457,737

4.60%

345,774

Alan Chi Wai Wong

3,492,790

4.64%

345,774

Andrew Peter Maund

3,457,737

4.60%

345,774

 

*In addition to the above, and as also set out in the Company's Admission Document, Richard Hamer, Richard Marley and Marc Castells have each agreed to provide, respectively,1,524,000, 1,238,000 and 1,238,000 of their ordinary shares to the Company to be used to satisfy an option granted to Ian Lankshear, CEO, over 4,000,000 ordinary shares under the Company's 2022 LTIP. These options are exercisable at 50p per share from 24 May 2024 until 1 December 2024.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AIMFFFILESIVFIF
12
Date   Source Headline
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResult of WRAP Retail Offer & Notice of GM
28th May 20246:00 pmRNSHoldings in Company
24th May 20247:01 amRNSWRAP Retail Offer for up to £0.3 million
24th May 20247:00 amRNSResult of Placing and Subscription
23rd May 20244:47 pmRNSProposed equity fundraising via ABB
14th May 20247:00 amRNSTrading Update
13th May 20247:00 amRNSAppointment of Chief Financial Officer
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSGrant of Options under Long Term Incentive Plan
4th Apr 20247:00 amRNSExercise of Warrants, Issue of Equity & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
20th Mar 20249:08 amRNSAppointment of Joint Broker
18th Mar 202412:40 pmRNSResult of General Meeting & Total Voting Rights
18th Mar 20247:00 amRNSExercise of Warrants, Issue of Equity & TVR
4th Mar 20247:00 amRNSArm-Based Technology Contract Win
29th Feb 20247:00 amRNSReceipt of R&D tax credit
28th Feb 20247:00 amRNSSignificant c.US$20 million Supply Win
27th Feb 20242:24 pmRNSPlacing to raise £1.1 million and notice of GM
26th Feb 20247:00 amRNSHalf-year Results
19th Feb 20247:00 amRNSNotice of Results and Investor Presentation
14th Feb 202411:49 amRNSHolding(s) in Company
5th Feb 20247:00 amRNSAppointment of Chief Financial Officer
12th Jan 20247:00 amRNSPost Quantum Cryptography Accelerators IP Release
29th Dec 20231:00 pmRNSTotal Voting Rights
22nd Dec 20237:00 amRNSEnSilica awarded initial mandate for telecoms ASIC
21st Dec 202312:51 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSPlacing to Raise £1.56m & New Business Update
28th Nov 202312:27 pmRNSResult of AGM
28th Nov 20237:00 amRNSAGM Statement & Trading Update for the Half Year
10th Oct 20237:01 amRNSProduction tape-out milestone of industrial ASIC
10th Oct 20237:00 amRNSAudited Full Year Results
3rd Oct 20237:00 amRNSNotice of annual results & investor presentation
13th Sep 20237:00 amRNSUS$7m e-mobility sensor ASIC supply contract win
1st Sep 20237:00 amRNSEnSilica secures follow-on $2.4m contract
30th Aug 20237:00 amRNSEUR2.5m Satellite Broadband Chip Contract Secured
22nd May 20237:00 amRNSAdditional automotive ASIC supply mandate
27th Apr 20237:00 amRNSTrading Update
14th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:01 amRNSDirectorate Change
11th Apr 20237:00 amRNSASIC Contract Extension
3rd Apr 20237:00 amRNS$2.4m contract secured with existing customer
31st Mar 20236:00 pmRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
21st Mar 20232:05 pmRNSSecond Price Monitoring Extn
21st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSResult of Retail Offer
9th Mar 20237:01 amRNSRetail Offer to raise up to £0.5 million
9th Mar 20237:00 amRNSPlacing & Subscription Raises £2m & Retail Offer
17th Feb 202311:05 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.